ARQT Q2 2023 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$4M85.0% margin

Operating Income

-$67M-1286.4% margin

Net Income

-$71M-1367.8% margin

EPS (Diluted)

$-1.16

QoQ Revenue Growth

+86.6%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$67M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$321M

Total Liabilities

$240M

Stockholders' Equity

$81M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$4M	-$234,000	+1986.3%
Operating Income	-$67M	-$66M	-1.4%
Net Income	-$71M	-$67M	-5.3%